Aptar - International Pharmaceutical Industry

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

News

Aptar Pharma’s Preservative-Free Multidose Dispenser Approved for Anti-Allergy Treatment by French Regulatory Agency ANSM

Aptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved delivery device for Bausch+Lomb’s Levofree Multidose in Franc...

26 June 2018 News approved | Aptar

Continue Reading →

News

Aptar Pharma and Propeller Health Partner to Develop Digital Medicine Platform Across Therapeutic Areas

Collaboration also includes strategic investment by Aptar Pharma; will add connectivity to drug-delivery routes to improve adherence and treatment outcomes Crystal L...

31 May 2018 News Aptar | digital

Continue Reading →

News

Aptar Pharma to Unveil Inhalation Drug Delivery Solutions at CPhI China 2018

Aptar Pharma, a leading drug delivery systems provider, is pleased to be exhibiting once again at CPhI China 2018, taking place from June 20-22 at the Shanghai ...